US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist
  • 35.435
  • +0.685+1.97%
Trading Dec 2 14:25 ET
2.40BMarket Cap-30547P/E (TTM)

About CG Oncology Company

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.

Company Profile

SymbolCGON
Company NameCG Oncology
Listing DateJan 25, 2024
Issue Price19.00
Founded2010
CEOMr. Arthur Kuan
MarketNASDAQ
Employees61
Fiscal Year Ends12-31
Address400 Spectrum Center Drive,Suite 2040
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-409-3700
Websitehttp://www.cgoncology.com

Company Executives

  • Name
  • Position
  • Salary
  • Arthur Kuan
  • Chairman of the Board and Chief Executive Officer
  • 3.74M
  • Ambaw Bellete
  • President and Chief Operating Officer
  • 2.85M
  • Dr. Vijay Kasturi, M.D.
  • Chief Medical Officer
  • 2.36M
  • Corleen M. Roche
  • Chief Financial Officer and Secretary
  • --
  • Dr. Leonard E. Post, PhD
  • Lead Independent Director
  • 77.54K
  • Dr. James J. Mule
  • Independent Director
  • 198.00K
  • Dr. Brian Liu, M.D.
  • Independent Director
  • --
  • Susan E. Graf
  • Independent Director
  • 599.04K
  • Hong Fang Song
  • Independent Director
  • --
  • Victor Tong, Jr
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data